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Background: The exceptional physical-chemical properties of carbon nanotubes have lead to their use in diverse
commercial and biomedical applications. However, their utilization has raised concerns about human exposure that
may predispose individuals to adverse health risks. The present study investigated the susceptibility to cardiac
ischemic injury following a single exposure to various forms of multi-walled carbon nanotubes (MWCNTs). It was
hypothesized that oropharyngeal aspiration of MWCNTs exacerbates myocardial ischemia and reperfusion injury
(I/R injury).
Methods: Oropharyngeal aspiration was performed on male C57BL/6J mice with a single amount of MWCNT (0.01
- 100 μg) suspended in 100 μL of a surfactant saline (SS) solution. Three forms of MWCNTs were used in this study:
unmodified, commercial grade (C-grade), and functionalized forms that were modified either by acid treatment
(carboxylated, COOH) or nitrogenation (N-doped) and a SS vehicle. The pulmonary inflammation, serum cytokine
profile and cardiac ischemic/reperfusion (I/R) injury were assessed at 1, 7 and 28 days post-aspiration.
Results: Pulmonary response to MWCNT oropharyngeal aspiration assessed by bronchoalveolar lavage fluid (BALF)
revealed modest increases in protein and inflammatory cell recruitment. Lung histology showed modest tissue
inflammation as compared to the SS group. Serum levels of eotaxin were significantly elevated in the carboxylated
MWCNT aspirated mice 1 day post exposure. Oropharyngeal aspiration of all three forms of MWCNTs resulted in a
time and/or dose-dependent exacerbation of myocardial infarction. The severity of myocardial injury varied with the
form of MWCNTs used. The N-doped MWCNT produced the greatest expansion of the infarct at any time point and
required a log concentration lower to establish a no effect level. The expansion of the I/R injury remained
significantly elevated at 28 days following aspiration of the COOH and N-doped forms, but not the C-grade as
compared to SS.
Conclusion: Our results suggest that oropharyngeal aspiration of MWCNT promotes increased susceptibility of
cardiac tissue to ischemia/reperfusion injury without a significant pulmonary inflammatory response. The cardiac
injury effects were observed at low concentrations of MWCNTs and presence of MWCNTs may pose a significant
risk to the cardiovascular system.
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The last decade has witnessed tremendous advances in
the field of nanotechnology, with the worldwide market
for products produced using nanotechnology estimated to
approach US $1 trillion by 2015 [1]. However, the growth
in development of these materials is not matched by a pa-
rallel understanding of potential exposure and health risks
[2].
Multi-walled carbon nanotubes (MWCNTs) are com-
prised of cylindrically arranged graphite sheets with a na-
noscale diameter. They are manufactured predominantly
by electrical arc discharge, laser ablation and chemical
vapor deposition processes [3]. Carbon nanotubes have
potential applications in medical and electronic devices,
supercapacitors, batteries and in the automotive and aero-
space industries [4]. Because of the rapid development
and application of MWCNTs, numerous avenues of ex-
posure to these materials exist, as does the potential for
unforeseen biological impacts.
Myocardial ischemia (MI) is one of the largest killers
of Americans. In 2006, mortality from MI in the United
States was 141,462 [5]. Reperfusion of ischemic myocar-
dium is an absolute necessity to salvage tissue from
eventual death and for ultimate limitation of infarct size.
However, reperfusion after ischemia is associated with
pathologic changes that cause additional myocardial
damage and may significantly contribute to myocardial
infarction size. This so-called ‘reperfusion injury’ results
from the activation of a series of inflammatory mediators
[6].
Despite increasing use of carbon nanotubes there re-
mains limited research on the safety and potentially detri-
mental effects to human health. In most existing studies
of carbon nanotube exposure, MWCNTs have been
shown to potentiate allergic, inflammatory and fibrotic
pulmonary responses [7-9]. Consistent with other reports,
we have recently demonstrated that mice instilled with
MWCNTs exhibited increased inflammatory cell activa-
tion, collagen deposition and granuloma formation in the
lung tissue which correlated with impaired pulmonary
function [10,11].
Inspite of a rapidly increasing knowledge of the po-
tential adverse pulmonary effects of carbon nanotubes,Table 1 MWCNT Characteristics
MWCNT
form
Mean
Diameter (nm)
Length
Range (μm)
Raman
Band ratio
(R)=ID/IG
Metal
Conte
TGA (
C-grade 22.5 ± 1.3 10 - 100 0.29 4.80
COOH 19.1 ± 1.6 40 - 100 0.35 5.15
N-doped 23.3 ± 1.5 50 - 80 0.93 3.68our knowledge of the impact of carbon nanotubes on
the cardiovascular system lags behind and has largely
been limited to studies of single-walled carbon nano-
tubes (SWCNTs). These reports provide evidence for
microvascular endothelial cell dysfunction, acceleration of
atherosclerotic plaque evolution and pulmonary and peri-
pheral vascular thrombosis [12-14]. In addition, SWCNTs
may alter the arterial baroreflex function thus affecting
the regulation of autonomic cardiovascular control [15].
While the impact of exposure to engineered nanoma-
terials on the cardiovascular system is largely unknown,
a growing body of evidence from epidemiological and
toxicological studies provides a strong link between pu-
lmonary exposure of ambient particulate matter and in-
creased cardiovascular morbidity and mortality [16-18].
Therefore, based upon limited studies with SWCNTs
and our understanding of the cardiovascular effects of
ambient air pollution particles, and the role of inflamma-
tion in the cardiac response to ischemia and reperfusion,
it is plausible that MWCNT exposure may exacerbate I/R
injury in the myocardium. To date there is lack of defini-
tive studies investigating the effect of pulmonary exposure
to MWCNT and cardiac injury. Therefore, the present
study was designed to evaluate the susceptibility to cardiac
ischemia injury following exposure to MWCNTs. We re-
port here, for the first time, a concentration- and time-
dependent effect of an acute MWCNT exposure and the
influence of the physico-chemical properties of the
MWCNTs on cardiac ischemic reperfusion injury.
Results
Multi-Walled Carbon Nanotube Characterization
All three forms of the MWCNTs used in this study had
similar physical dimensions, with mean tube diameters
ranging from 19 - 23 nm and overall length from 10 -
100 μm (Table 1 and Figure 1). Additional information
detailing the diameter distributions and electron mi-
croscopy images of the bulk MWCNTs are provided in
Additional file 1: Figures S2 - S10. Importantly, as shown
in the transmission electron micrograph (Figure 1C),
N-doped MWCNTs exhibit an internal structure diffe-
rent from pristine and COOH forms. TGA results for
the 3 forms of bulk MWCNTs showed no initial massAsh
nt by
% weight)
Energy Dispersive
spectra based
concentrations
Surface
area (m2/g)
Pore volume
(cm3/g)
C = 99.6 N = 0.0
O = 0.0 Fe = 0.04
113.10 0.69
C = 96.5 N = 0.0
O = 3.5 Fe = 0.07
111.39 0.60
C = 80.8 N = 19.2
O = 0.0 Fe = 0.04
140.15 0.93
Figure 1 Representative electron micrographs of the Commercial grade (C-grade, Panel A), carboxylated (COOH, Panel B) and Nitrogen
doped (N-doped, Panel C) MWCNTs. Left hand panels are scanning EM (SEM) of the bulk dry CNTs. Right hand panels are transmission EM
(TEM) of MWCNT in suspension. Black arrows indicate presence of Fe metal catalyst inclusion within the MWCNT. Red arrows identify bamboo
structure in N-doped MWNCTs.
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analysis. The ash content for all 3 forms of MWCNT ran-
ged between 3.7 - 5.1% weight (Table 1) with the ash ap-
pearance an orange-brown color, suggesting that their
catalyst may be (Fe) iron-based. Subsequent x-ray adsorp-
tion spectral content analysis confirmed the present of
Fe particles in the range of 0.04 - 0.07% atomic weight.
Additionally, spectral analysis confirmed the functionali-
zation by nitrogen doping (N-doped) and the higher oxy-
gen content in the carboxylated (COOH) MWCNTs that
were not present in the C-grade MWCNTs (Table 1 and
Additional file 1: Figures S4, S7 and S10).The presence of a strong disorder band (ID/IG peak
ratio) suggests the existence of structural defects as de-
termined by Raman spectroscopy. Representative traces
show the presence of the D and G band peaks and the
ratios of the strengths of these bands (R = ID/IG) was
used to quantify defects in the carbon nanostructure and
reflect the defects in the functionalized COOH and
N-doped versions of the MWCNTs (Additional file 1:
FigureS1). The R values were relatively higher for
carboxylated and N-doped samples confirming an in-
crease in the intrinsic disorder due to acid functiona-
lization and nitrogen-doping (Table 1).
Table 2 MWCNT Suspension Characteristics
MWCNT form Zeta Potential IEP Hydrodynamic Size (Major and Minor Peak)
C-grade - 44.6 mV 3.5 pH 180 ± 50 nm and 1100 ± 200 nm
COOH - 37.9 mV 2.0 pH 140 ± 50 nm and 700 ± 150 nm
N-doped - 40.6 mV 3.0 pH 150 ± 50 nm and 1300 ± 250 nm
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determined to be 113.10 m2/g for C-grade, 111.39 m2/g
for COOH and 140.15 m2/g for the N-doped based
on the BET equation [19]. The pore volume of the
MWCNTs, defined as the ratio of the MWCNTs air vo-
lume to their total volume, was determined to be 0.69
cm3/g for C-grade, 0.60 cm3/g for COOH and 0.93
cm3/g for the N-doped utilizing the BJH method [20]
(Table 1).
Two major peaks were observed in the hydrodynamic
size distribution of each MWCNT suspension sample
(Table 2). The C-grade MWCNTs displayed a major
peak at 180 ± 50 nm, with a minor peak at 1100 ± 200
nm while both the COOH and the N-doped MWCNTs
showed major peaks at 140 ± 50 nm, with a minor peak
at 700 ± 150 nm. The slightly smaller mean size of the
peaks for the COOH and N-doped MWCNT reflects
the influence of the functionalization on the dispersibi-
lity of the MWCNTs. The larger sized peaks observed
with the C-grade MWCNTs were likely due to bundling
of the nanotubes through hydrophobic interaction and
pi-stacking. Zeta potential and isoelectric point (IEP) are
primary indicators for describing the surface charge and
stability of a nanoparticle suspension. As reported in
Table 2, at neutral pH, the zeta potentials of the C-grade,
COOH and N-doped forms of the MWCNTs were in
the range of - 37 to - 45 mV which suggested a good sta-
bility of these samples at neutral pH. The IEP of the
MWCNT suspensions ranged from pH + 2.0 - 3.5 and
thus at physiological pH the MWCNT suspensions were
stable and not precipitating.Table 3 Pulmonary Bronchoalveolar Lavage Fluid Protein (μg
Treatment Dose 1 Day Post Aspiration
SS 0.07 ± 0.01
C-grade 1 μg 0.18 ± 0.01*
100 μg 0.27 ± 0.04*†
COOH 1 μg 0.19 ± 0.02
100 μg 0.30 ± 0.14
N-doped 1 μg 0.22 ± 0.02*
100 μg 0.24 ± 0.04*
Bronchoalveolar lavage fluid (BALF) protein levels (μg/ml) following oropharyngeal
(10% surfactant saline). The protein levels were performed on pooled aliquots of th
mean ± SEM for n = 4. * indicates significance from SS, † indicates significance fromOropharyngeal Aspiration of MWCNT Induces a Modest
Pulmonary Inflammatory Response
Pulmonary inflammation was assessed by determining
BALF protein concentration and cell counts. We found
elevated protein within the BALF with the 1 and 100 μg
for all the three forms of MWCNTs at one day (1 day)
post-oropharyngeal aspiration (Table 3). There was no dif-
ference in BALF protein levels between the SS and 3
forms of MWCNT at the later time points of seven day
(7 day) and twenty-eight day (28 day) post-oropharyngeal
aspiration (Table 3).
Modest pulmonary inflammation that consisted of in-
creased numbers of macrophages and neutrophils was
observed at 1 day and 7 day for all the three forms of
MWCNTs (Table 4). In addition, eosinophils were pre-
sent at 1 day following oropharyngeal aspiration of
MWCNT, but waned by 7 days and were absent at 28
days. Eosinophil numbers were greatest with the oropha-
ryngeal aspiration of the two functionalized forms of
MWCNTs (i.e., COOH and N-doped). Overall, the BALF
cell counts were generally higher in the 100 μg MWCNT
than the 1 μg MWCNT.
Lung histopathology revealed modest alveolar and pe-
ribronchial inflammation with cellular infiltration of the
alveolar septae at 1 day post-oropharyngeal aspiration of
100 μg MWCNTs (Figure 2). The presence of MWCNT
agglomerates at various locations in the lung was
observed for all three forms of MWCNTs. The absence
of any striking differences in agglomeration trends of
various MWCNTs was expected since all the MWCNT
samples exhibited similar zeta potential values. Similar/ml)
7 Day Post Aspiration 28 Day Post Aspiration
0.03 ± 0.01 0.15 ± 0.01
0.08 ± 0.01 0.12 ± 0.02
0.12 ± 0.03 0.12 ± 0.01
0.07 ± 0.01 0.12 ± 0.01
0.12 ± 0.03 0.12 ± 0.01
0.05 ± 0.01 0.17 ± 0.01
0.09 ± 0.01 0.19 ± 0.01
aspiration of three forms of MWCNTs at 1μg and 100 μg or SS vehicle control
e BALF at 1 day, 7 day and 28 day post aspiration. Data reported as
1 μg dose within the same MWCNT form, P ≤ 0.05.
Table 4 Pulmonary BALF Cell Counts at 1, 7 and 28 Days Following Oropharyngeal Aspiration of MWCNTs
Treatment Dose Total Cells x 105 Macrophages x105 Neutrophils x 105 Eosinophils x 105 Lymphocytes x 105 Epithelial Cells x 105
1 Day
SS 1.80 ± 0.15 1.49 ± 0.12 0.01 ± 0.01 0.0 ± 0.0 0.0 ± 0.0 0.29 ± 0.03
C-grade 1 μg 2.25 ± 0.25 0.76 ± 0.08 1.65 ± 0.21 0.0 ± 0.0 0.0 ± 0.0 0.09 ± 0.01
100 μg 4.64 ± 0.60* 1.12 ± 0.13 3.36 ± 0.71* 0.0 ± 0.0 0.0 ± 0.0 0.14 ± 0.05
COOH 1 μg 4.19 ± 0.45 1.42 ± 0.08 2.60 ± 0.38* 0.01 ± 0.01 0.0 ± 0.0 0.14 ± 0.02*
100 μg 5.30 ± 1.57* 1.25 ± 0.35 3.92 ± 1.38* 0.08 ± 0.04 0.0 ± 0.0 0.03 ± 0.01*
N-doped 1 μg 7.16 ± 0.24* 2.06 ± 0.35 4.75± 0.27* 0.01 ± 0.01 0.0 ± 0.0 0.27 ± 0.04
100 μg 6.22 ± 1.14* 1.84 ± 0.40 4.21 ± 0.75* 0.05 ± 0.02 0.0 ± 0.0 0.15 ± 0.01
7 Day
SS 4.44 ± 0.15 4.20 ± 0.14 0.0 ± 0.0 0.0 ± 0.0 0.03 ± 0.01 0.19 ± 0.01
C-grade 1 μg 4.78 ± 1.21 4.46 ± 1.17 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.31 ± 0.13
100 μg 2.80 ± 0.72 2.53 ± 0.67 0.04 ± 0.01 0.03 ± 0.01 0.0 ± 0.0 0.18 ± 0.07
COOH 1 μg 1.33 ± 0.08 1.07 ± 0.08* 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.25 ± 0.03
100 μg 3.15 ± 0.05 2.63 ± 0.12* 0.19 ± 0.08 0.12 ± 0.06 0.03 ± 0.01 0.16 ± 0.01
N-doped 1 μg 5.61 ± 1.67 5.04 ± 1.52 0.0 ± 0.0 0.0 ± 0.0 0.06 ± 0.04 0.49 ± 0.16
100 μg 4.92 ± 0.75 4.35 ± 0.86 0.03 ± 0.03 0.0 ± 0.0 0.07 ± 0.04 0.46 ± 0.09
28 Day
SS 1.30 ± 0.24 1.24 ± 0.20 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.06 ± 0.03
C-grade 1μg 1.04 ± 0.35 0.87 ± 0.26 0.0 ± 0.0 0.01 ± 0.01 0.0 ± 0.0 0.15 ± 0.07
100 μg 1.48 ± 0.29 1.37 ± 0.27 0.0 ± 0.0 0.0 ± 0.0 0.01± 0.01 0.10 ± 0.02
COOH 1μg 1.29 ± 0.07 1.15 ± 0.08 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.13± 0.02
100 μg 1.74 ± 0.23 1.60 ± 0.22 0.02 ± 0.01 0.0 ± 0.0 0.0 ± 0.0 0.10 ± 0.01
N-doped 1 μg 0.92 ± 0.29 0.86 ± 0.28 0.0 ± 0.0 0.0 ± 0.0 0.06 ± 0.04 0.05 ± 0.01
100 μg 1.27 ± 0.11 1.15 ± 0.10 0.0 ± 0.0 0.0 ± 0.0 0.07 ± 0.04 0.11 ± 0.01
Bronchoalveolar lavage fluid cell counts following oropharyngeal aspiration of three forms of MWCNTs at 1μg and 100 μg or SS vehicle control (10% surfactant saline).
The cell counts were performed at 1 day, 7 day and 28 day post-instillation. Data reported as mean ± SEM for n = 4. * indicates significance from SS, † indicates
significance from 1 μg dose in same MWCNT form, P ≤ 0.05.
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μg MWCNTs at 1 day post oropharyngeal aspiration
(Additional file 1: Figures S11 - S13). There appears to
be a waning of the general inflammatory response in the
lungs at 7 days following oropharyngeal aspiration of
MWCNT. However, at 7 and 28 days post-oropharyngeal
aspiration the development of granuloma-like lesions
around deposits of MWCNTs appeared with 100 μg
(Additional file 1: Figures S12 andS13).
Effect of Oropharyngeal Aspiration of MWCNT on
circulating leukocytes, red blood cells and platelets
Total and differential leukocyte counts were performed
after oropharyngeal aspiration of 100 μg of each of
the three forms of MWCNTs 1 day post-oropharyngeal
aspiration and showed increased number of total leu-
kocytes (Table 5). The Neutrophil count in the COOH
group was statistically significant larger than the SS, the
C-grade and the N-doped MWCNTs groups. We did
not observe any statistically significant differences in thetotal red blood cell or the platelet counts between the SS
and the three forms MWCNTs (Table 5).
Effect of Oropahryngeal Aspiration of MWCNT on
Circulating Cytokine Levels
Because we were interested in determining if any circu-
lating inflammatory mediators might be associated with
the susceptibility of the cardiac tissue to ischemic dama-
ge, we evaluated serum levels of selected cytokines that
previously have been described in pulmonary responses
to particulate and MWCNT exposure, or cardiac ische-
mia and reperfusion [7,21]. Serum cytokine analysis was
performed on blood samples collected at 1 day post-
oropharyngeal aspiration of 100 μg MWCNTs. We found
no significant difference in serum cytokine between the
SS exposed mice and the C-grade MWCNT exposed
mice (Table 6). There was a significant increase in serum
levels of eotaxin following pulmonary exposure to COOH
MWCNTs with increased levels of IL-6, IL-10, IL-12
(p70) and KC (keratinocyte derived chemokine) following
Figure 2 Representative histological sections of the left lung 1 day post oropharyngeal aspiration of vehicle control (SS) and 100 μg
of each of the MWCNT forms: Commercial grade (C-grade), Carboxylated (COOH) and Nitrogen doped (N-doped). Images are of H&E
stained 8μm thick cross-sections of left lung. Larger panel images were captured at 10x magnification and inset images at 40x magnification.
Arrows indicate deposits of MWCNT.
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pared to SS (Table 6). While oropharyngeal aspiration of
the N-doped MWCNTs did not lead to any significantly
increased circulating levels of these cytokines, there was
small non significant elevations of IL-10, IL-12(p40), IL-
13 and MIP1α (Table 6). Additional ELISA based analysis
of eotaxin, Il-6, IL-1β and TNF- α were conducted in a
separate set of rat serum from each experimental group
(n = 6) as verification of of multiplex results. The re-
evaluation for eoxtaxin and IL-6 were not different from
the original values and were not reported. The result
from the IL-1β assay revealed similar variability in the
cytokine levels within any group as the multiplex data
without any statistically significant differences between
the groups while TNF-α was undetectable (Table 6).Table 5 Blood Cell Counts 1 Day post Oropharyngeal Aspirati
WBC Type/Treatment SS C-
Total WBC Count (10^3/μl) 4.18 ± 0.27 3.
Neutrophils 0.45 ± 0.06 0.
Lymphocytes 3.49 ± 0.24 3.
Monocytes 0.19 ± 0.03 0.
Eosinophils OO 0.03 ± 0.01 0.
RBC Count (10^6/μl) 8.49 ± 0.22 8.
PTL Count (10^3/μl) 1091.5 ± 79.8 77
Blood Cell Counts following oropharyngeal aspiration of three forms of MWCNTs at
performed at 1 day post aspiration. Data reported as mean ± SEM for n = 6. * indic
N-doped MWCNT by one way ANOVA, P ≤ 0.05.MWCNTs Exacerbate Myocardial I/R Injury at 1, 7 and 28
Days Following Oropharyngeal Aspiration
To determine whether there was a time-dependent effect
on myocardial I/R injury following oropharyngeal aspi-
ration of MWCNTs, this exposure apporach was per-
formed in mice with 100 μg C-grade, COOH or N-doped
MWCNTs suspended in 100 μl of SS. The mice were then
subjected to the cardiac ischemic reperfusion (I/R) injury
protocol at 1 day, 7 days and 28 days post-oropharyngeal
aspiration. At 1 day following oropharyngeal aspiration of
100 μg each of three forms of MWCNTs, coronary artery
occlusion resulted in a ≥ 2-fold increase in left ventricle
infarct size (Figure 3A). The oropharyngeal aspiration of
the COOH and N-doped MWCNTs resulted in a signifi-
cantly greater infarct size than the C-grade MWCNTson of 100 μg MWCNTs
grade COOH N-doped
75 ± 0.45 5.03 ± 0.68 4.4 ± 0.21
40 ± 0.08 0.81 ± 0.08 *†# 0.40 ± 0.03
04 ± 0.33 3.78 ± 0.56 3.72 ± 0.17
22 ± 0.05 1.13 ± 0.86 0.25 ± 0.05
07 ± 0.01 0.04 ± 0.01 0.01 ± 0.01
82 ± 0.28 8.91 ± 0.23 8.74 ± 3.07
1.3 ± 151.1 977.3 ± 102.3 980.3 ± 66.0
100 μg or SS vehicle control (10% surfactant saline). The cell counts were
ates significance from SS, † indicates significance from C-grade and # from
Table 6 Serum Cytokine Profile 1 Day post Oropharyngeal Aspiration of 100 μg MWCNTs (pg/ml)
Cytokine/Treatment SS C-grade COOH N-doped
Eotaxin 306.4 ± 75.0 276.9 ± 42.3 903.8 ± 278.6* 302.6 ± 22
IL-5 16.3 ± 1.1 30.3 ± 10.0 11.6 ± 3.0 51.2 ± 28.3
IL-6 9.2 ± 1.3 16.1 ± 7.8 137.8 ± 66.0 42.4 ± 26.4
IL-10 8.5 ± 1.9 8.6 ± 3.4 24.6 ± 15.4 125.8 ± 118.1
IL-12 (p40) 17.5 ± 3.6 20.3 ± 5.3 16.3 ± 2.2 12.6 ± 2.2
IL-12 (p70) 35 ± 5.9 55.3 ± 34.9 22.9 ± 3.1 516.7 ± 464.5
IL-13 446.3 ± 41.6 326.9 ± 38.2 365.3 ± 45.6 848.3 ± 490.0
KC 173.2 ± 32.6 97.1 ± 7.1 645.1 ± 441.3 183.5 ± 53.1
MCP-1 39.6 ± 12.3 36.6 ± 8.6 46.6 ± 6.0 136.1 ± 104.4
MIP1α 38.2 ± 9.3 71.1 ± 4.5 42.0 ± 4.4 128.1 ± 86.9
MIP-1β 129.0 ± 11.4 70.2 ± 22.3 82.8 ± 29.6 136.2 ± 48.8
MIP-2 155.4 ± 27.7 86.4 ± 43.8 209.1 ± 38.9 102.4 ± 26.4
RANTES 30.7 ± 5.8 36.1 ± 6.4 57.5 ± 12.0 65.9 ± 38.5
†IL-1β 33.25 ± 3.83 222.86 ±114.71 127.66 ± 45.32 47.25 ± 7.36
†TNF-α N.D. N.D. N.D. N.D.
Serum cytokine profile by Lincoplex Cytokine/Chemokine 20 plex kit 1 day post oropharyngeal aspiration of three forms of MWCNTs at 100 μg and vehicle control
SS (10% surfactant saline). Data reported as mean ± SEM for n = 4. * indicates significance from SS, P ≤ 0.05.
† IL-1β and TNF-α profile 1 day post oropharyngeal aspiration of three forms of MWCNTs at 100 μg and vehicle control SS (10% surfactant saline) by ELISA. Data
reported as mean ± SEM for n = 6. N.D. not detected, P ≤ 0.05 by one way- ANOVA.
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sent at 7 days following oropharyngeal aspiration of each
of the three forms of MWCNTs (Figure 3B). By 28 days
post-oropharyngeal aspiration, a decrease in infarct expan-
sion was observed in all three groups, (Figure 3C). Overall,
the N-doped and COOH MWCNT exposed mice dis-
played an early and sustained elevation in extent of I/R in-
jury that was reduced but still evident and significantly
elevated at 28 days, while the C-grade MWCNT exposed
mice showed an elevated infarct size at 1 and 7 days
following oropharyngeal aspiration, but not significantly
elevated 28 days following oropharyngeal aspiration of
MWCNT.
Concentration-Dependent Exacerbation of Myocardial I/R
Injury Following Oropharyngeal Aspiration of MWCNTs
Since oropharyngeal aspiration of 100 μg MWCNT re-
sulted in significant infarct expansion, we attempted to
determine if there was a concentration-dependent car-
diac I/R injury response to MWCNTs. Oropharyngeal
aspiration was performed on mice with each form of
MWCNTs between 0.01 μg and 100 μg and I/R injury
was assessed at 1, 7 and 28 days post-oropharyngeal as-
piration (Figure 4). At 1 day post-oropharyngeal aspi-
ration of C-grade and COOH MWCNTs, there was a
significant exacerbation in the infarct size at 1 μg and
larger as compared to the SS group (Figure 4A and B).
For the C-grade and COOH MWCNT exposed mice, a
no observable effect level was found at 0.1 μg MWCNTs
(Figure 4A and B). Since the C- grade and the COOHMWCNTs displayed no statistical significant differences
from S/S for 0.1 μg at 1 day and 7 days we chose not to
examine the 0.1 μg at 28 days. However, at one day fol-
lowing oropharyngeal aspiration, the N-doped MWCNT
exposed mice had a significantly elevated infarct size at
0.1 μg and a no observable effect level was found at 0.01
μg MWCNT (Figure 4C). Because there significant ele-
vations in I/R injury area with 0.1 μg the 1 and 10 μg
concentrations were not examined in the 7 and 28 day
time points. Oropharyngeal aspiration of the C-grade
and COOH forms of MWCNTs did not demonstrate a
concentration-response relationship but rather exhibited
a threshold effect of infarct expansion; only with the oro-
pharyngeal aspiration of N-doped MWCNT did there ap-
pear to be a concentration -response relationship of mass
dose and infarct size.
Based on the results of the 1 day MWCNT oropharyn-
geal aspiration experiments, we also examined a limited
concentration-response series at 7 days and 28 days for
all forms of the MWCNTs. The C-grade MWCNT I/R
injury response showed persistent expansion of the in-
farct at concentrations of 1 and 10 μg at 7 and 28 days
while the 100 μg concentration remained elevated at 7
days, but waned and was no longer statistically different
from SS instilled mice at 28 days post- oropharyngeal as-
piration (Figure 4A). The COOH MWCNT exposed
mice maintained a significant expansion of the infarct
size at 1 and 100 μg at both 7 and 28 days post- oropha-
ryngeal aspiration. However, there was also a waning of
the magnitude of the infarct expansion between 7 days
Figure 3 The time-dependent cardiac ischemic-reperfusion (I/R)
injury following vehicle control 10% surfactant/saline (SS) and
100 μg of each of the three forms of MWCNT: Commercial
grade (C-grade), carboxylated (COOH) and nitrogen doped
(N-doped). The cardiac I/R injuries were performed at 1 day (A), 7
day (B) and 28 day (C) post oropharyngeal aspiration of 100 μl of
the MWCNT suspension. Data are reported as mean ± sem with an
n = 6. * indicates statistical significance from the SS group and †
represent statistical significance from the c-grade group by ANOVA
with TUKEY post hoc analysis with significance at p < 0.05.
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the N-doped MWCNT exposed mice also displayed a
similar pattern with the lowest concentration (0.1 μg)that was significant at 1 day and remained persistent at
both 7 days and 28 days but was smaller in magnitude at
the later time point (Figure 4C).
Discussion
Due to the diverse commercial utility of MWCNTs and
the limited knowledge about their potential health risks
on the cardiovascular system, the effect of pulmonary
MWCNT exposure on an imposed cardiac stress was
evaluated. We report, for the first time, that oropharyn-
geal aspiration of three different forms of MWCNTs
promotes an increased susceptibility of cardiac tissue to
ischemic reperfusion (I/R) injury. These effects were
observed at a concentration as low as 0.1 μg MWCNT
per animal and persisted for 28 days following a single
oropharyngeal aspiration. We suggest that a pulmonary
exposure to MWCNTs may pose a significant risk to the
injured heart, particularly at low doses where overt pul-
monary toxicity is not observed.
The safety of MWCNTs is still in debate due to the
lack of systematic and complete toxicity evaluation as
well as a limited understanding of the human exposure
levels in occupational settings [22]. Current proposed
guidelines by the National Institute for Occupational
Safety and Health (NIOSH) limits exposure to 7 μg/m3,
which is the lowest detectable level of airborne CNT by
the latest analytical method [23]. The present study in-
volved delivering a single defined amount of MWCNTs
in a log order by oropharyngeal aspiration and exami-
ning pulmonary and cardiovascular endpoints at multiple
time points. The utilization of such acute high concentra-
tions to probe potential effects is a standard approach in
toxicology and experimental pathology for initially surve-
ying adverse effects [24]. While oropharyngeal aspiration
provides a natural route of entry into the host and has
been a method for the introduction of a variety of toxi-
cants into the lungs [25] there is continued discussion
regarding the real world relevance of this route of expo-
sure. The pulmonary toxicity effects of CNT aspiration
have shown to be comparable between inhalation and
oropharyngeal aspiration [26]. Even with these caveats
the chosen oropharyngeal aspiration approach allows
primary responses to substance exposure to be studied
Figure 4 Graphs depicting the extent time- and dose-dependent cardiac ischemic reperfusion (I/R) injury following oropharyngeal
aspiration of vehicle control 10% surfactant/saline (SS) and 3 forms of the MWCNT: Commercial grade (C-grade) Row A, carboxylated
(COOH) Row B and nitrogen doped (N-doped) Row C. The cardiac I/R injuries were performed at 1 day (left most panels), 7 day (middle
panels) and 28 day (right most panels) post aspiration of 100 μl of the MWCNT suspension. Data are reported as mean ± sem with an n = 6.
* indicates statistical significance from the SS group, § from 0.01 μg, † from 0.1 μg ‡ from 1.0 μg and # from 10 μg dosing as determined by
ANOVA with TUKEY post hoc analysis with significance at p < 0.05.
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come into play with chronic exposures.
Evidence accumulated from epidemiological studies con-
firms a significant pathogenic correlation between the in-
halation of small and ultrafine sized particles, including
nano-sized particles from ambient air and cardiovascular
events, such as angina, arrhythmia, ischemic heart failure
and sudden death [27]. Epidemiologic and experimental
studies have suggested an association between respiratoryexposure to ambient ultrafine particles (including particles
with a diameter < 100 nm) and the progression of cardio-
vascular disease [17,28]. A number of studies have also
shown that pulmonary inhalation of ultrafine particulate
matter generated from synthetic nanoparticles resulted
in development of vascular abnormalities, including athe-
rosclerosis, increased vascular tone and impaired en-
dothelial-dependent vascular dilation [14,29-31]. While
epidemiological and inhalation studies have provided
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posure may be a risk factor for adverse cardiac events
[12,27,32], no definitive study has identified a link between
exposure to MWCNTs and a negative impact on the
myocardium.
Various toxicological studies have demonstrated that
pulmonary deposition of MWCNTs caused an acute and
chronic pulmonary toxicity in animal models [7-9,11].
Pulmonary responses to MWCNT exposure include an
acute inflammatory phase, a progressive fibrotic respon-
se in the interstitium of the alveolar wall, and a granu-
lomatous inflammation enveloping airspace deposits of
MWCNT agglomerates [9,33].
In our experiments we observed similar pulmonary in-
flammatory responses as reported in the literature fol-
lowing oropharyngeal aspiration of MWCNTs that
peaked between 1 and 7 days and decreased by 28 days.
This result is similar to that described in time of an
acute inflammatory reaction which peaked at 7 days in
the mouse and resolved over a 56 day period [7,9,34].
The pulmonary inflammatory response in our study may
be related to how the MWCNTs were dispersed using a
clinical grade animal-based lung surfactant. Previous
reports have demonstrated that MWCNTs suspended in
a natural lung surfactant or synthetic lung surfactants
could influence both the lung dispersion and cytological
effects of the CNTs [35-37]. In addition, the presence of
proteins in the suspension that ultimately form a corona
around the CNTs are believed to modulate MWCNT
toxicity, phagocytosis and the inflammatory response
[38,39].
Lung histopathology showed persistence of MWCNTs
within the tissue that ultimately resulted in granuloma-
like lesion formation at both low and high concentration
at 28 days following instillation with each MWCNT type.
Our finding was consistent with chronic granuloma for-
mation reported earlier by us and others in rodent models
[10,11].
Our study demonstrated a modest pulmonary inflam-
matory response but a more robust cardiac infarct ex-
acerbation both in a time- and dose-dependent manner
following oropharyngeal aspiration of MWCNTs. Infarct
expansion remained evident at the highest concentration
at 7 days post- oropharyngeal aspiration. Although we
observed a diminution of the infarct size with all three
forms of MWCNTs with time, the expanded infarct was
still present as late as 28 days post- oropharyngeal aspi-
ration. This type of result may underlie the importance
of defining the endpoint of interest as to determining
systemic toxicological response. Overall the results of our
experiments contribute to the mounting evidence of the
harmful effects of air pollution and engineered nanoma-
terials on the cardiovascular system [13,17,40]. Lack of
blood supply or ischemia underlies many of the mostimportant diseases encountered by physicians, including
myocardial infarction, thrombotic stroke, embolic vascular
occlusions, and peripheral vascular insufficiency. Evidence
from animal studies suggests that reperfusion of ischemic
areas may contribute to further tissue damage (I/R injury)
[41]. I/R injury plays a key role in the pathophysiology of
myocardial tissue damage after thrombolysis, angioplasty,
or coronary artery bypass surgery [42-44]. We chose to in-
vestigate the effects of MWCNTs on an acute I/R injury
model to simulate the occurrence of the common cardio-
vascular events in an acute setting. The relative uniformity
in anatomy and physiological process found in the mouse
model allows experimental interpretations that can be
translated to the clinical setting [45]. As previously re-
ported although the topographical left coronary artery in
mice is not a functional left coronary artery as we under-
stand it in humans, [45] and the mouse model as used to
study the effects of ischemia reperfusion injury has been
shown to be reproducible [45,46]. Our experiments used a
20-min occlusion period. Thirty minutes is a more com-
mon occlusion period in this model, but those studies of
I/R injury are focused on mechanisms to reduce injury,
and the occlusion time is selected to produce a sufficiently
large infarction to permit measurable decreases associated
with treatment. In our experiments, we hypothesized that
treatment would exacerbate injury, and the occlusion time
was shortened to enable an accurate reflection of expan-
ded injury. The twenty-minute ligation of the LAD has
been reported previously in the murine model [47,48].
Studies have investigated the dose- and time- dependent
responses of pulmonary toxicity of MWCNTs after oro-
pharyngeal aspiration in mice [9,49]. Our experiments
illustrate a concentration- and time- dependent response of
cardiac toxicity after oropharyngeal aspiration of MWCNTs.
We observed a concentration-dependent effect with the
N-doped MWCNTs but not with either C-grade or
COOH MWCNTs. In contrast, the C-grade and COOH
MWCNTs exhibited a threshold response with 1 μg
MWCNT associated with a significant expansion of the
infarction. Surprisingly, at one day following oropharyn-
geal aspiration of the N-doped MWCNT, the infarct
was significantly expanded at of 0.1 μg.
The infarct exacerbation that we observed with the N-
doped MWCNTs may reflect its unique physicochemical
properties notably their bamboo-like structure and sur-
face charge distribution resulting in the augmentation of
the cardiovascular response. The presence of nitrogen
atoms during the nanotube growth process is known to
promote the growth of inner caps to yield structures that
resemble bamboo sticks [50]. Previously, some studies
found that N-doped MWCNTs exhibit different physio-
logical response since the bamboo-like rough surfaces
modify the van der Waal interactions between N-doped
nanotubes [51,52]. N-atoms often dope the carbon lattice
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tron (pyridinc, pyrrolic). Hence, a high doping percentage
of N (~19% in our case; see Table 1) may lead to the for-
mation of non-graphitic (pyridinc/pyrrolic) phases that
may act as localized charge centers. Previously, several
researchers have demonstrated differences in cytotoxicity,
hemo- and biocompatibility between pristine and N-
doped MWCNTs [51,52]. However, the exact role of N
atoms in the observation of such mitigated toxicity res-
ponses is yet to be understood. It is possible that the pre-
sence of large amount of N-atoms results in local charge
centers. Such charge centers assist N-doped MWCNT
interact more effectively with any polar entities compared
to pristine or COOH functionalized forms. In fact, N-
doped MWCNTs have been employed as electrodes in
redox-active cells due to their unique charge distribution
[53].
In addition to the potential role of nitrogen doping in
contributing to a more robust cardiac response, surface
area may also contribute to these differences. Physical
characteristics of MWCNTs such as small size, large sur-
face area and high reactivity, are cited as significant fac-
tors of their potential toxicity [12,27,32]. It has been
postulated that the large surface area (250–300 mg/m2)
of some MWCNTs may play a significant role in the de-
velopment of pulmonary effects [54]. In our results, it is
interesting to note that the most extensive cardiac injury
and dose sensitivity was associated with the N-doped
MWCNT that had the highest measured surface area.
However, there was no significant difference in the sur-
face area or hydrodynamic size estimates for the COOH
and C-grade MWCNTs but there were differences in the
time course of the cardiac I/R response. We believe that
surface area may be another contributing factor along
with the surface modification.
The exact mechanism by which MWCNTs may exhibit
cardiovascular toxicity is unknown. Mechanisms of nano-
particle cardiovascular toxicity postulated in the litera-
ture include oxidative stress, inflammation, emanating
in part, from pulmonary inflammation leading to athe-
rothrombosis [55]; translocation of inhaled particles to
the vasculature [56], direct effects on endothelial cells
and cardiovascular system [57,58] and/or effects on the
autonomic nervous system [55,59].
Systemic cytokine response to MWCNT oropharyn-
geal aspiration has not been adequately investigated al-
though studies have reported cytokine analysis of BALF
after pulmonary exposure to MWCNTs [11,36]. We there-
fore chose to study the circulating cytokine profile after
oropharyngeal aspiration of MWCNTs. A close correla-
tion between cytokines and I/R injury has been demons-
trated [21]. IL-6, IL-10, IL-12, KC have been implicated in
I/R injury after myocardial infarction [21,60,61]. IL-6 has
been shown to contribute to cardiovascular dysfunctioninduced by acute lung injury [62]. MWCNTs and SWCNTs
have been shown to provoke inflammation by induction of
the pro-inflammatory genes IL-1β and IL-6 [63]. Although
not statistically significant, we also found elevated levels of
IL-6, IL-10, IL-12, IL-13, KC and MIP1-α with the COOH
and the N-doped MWCNTs. IL-1β did not reveal any sta-
tistically significant differences compared to the SS and
across the three treatment groups.
Wang and co-workers demonstrated that pulmonary ex-
posure to MWCNTs induces an inflammatory response
marked by increased levels of Eotaxin (Ccl11) that pro-
mote inflammatory and fibrotic changes observed within
the lung [11]. We reported a statistically significant in-
crease in the level of Eotaxin with the COOH exposed
mice. Serum eotaxin levels have been associated with the
etiologies of cardiac injury and heart failure as well as the
regulation of inflammatory cell recruitment to infarcted
myocardial tissue for wound repair [64-66]. The increase
in the eosinophils with the COOH and the N-doped
MWCNTs instillation in mice in the BALF observed in
our experiments may suggest a possible link of Eotaxin to
increased response of the myocardium to an imposed
stress from I/R injury. The hematological assessment from
these groups at 24 hours post oropharyngeal aspirations
does not reflect a strong inflammatory either. As pre-
viously reported by Robertson there was no indication of
systemic inflammation at 24 hours after diesel exhaust
particle instillation although there were increased levels of
inflammatory mediators at 6 hours [67]. While there was
significant elevation in a common marker of inflammation
in the number of neutrophils from the COOH exposed
mice but overall WBC numbers remained in the normal
range and suggest there is no significant inflammatory
state. Any conclusion drawn from these observations must
be viewed with caution as the cytokines and blood cells
counts are known to rapidly change following an acute
pulmonary exposures and we do not provide direct evi-
dence for the role of these cytokines exacerbating the I/R
injury. It still remains a hypothesis that circulating cyto-
kines may prime target organs to response more robustly
to any imposed injury.
As previously demonstrated by Cozzi et al, oropharyn-
geal aspiration of mice with particulate matter increased
cardiac oxidative stress within the myocardium after I/R
injury [68]. Furthermore, it has also been shown that
carbon nanotubes in general can lead to reactive oxygen
species (ROS) generation [69]. Xia and co-workers have
shown that redox cycling can contribute to ROS produc-
tion. This can occur because of the presence of transi-
tion metals or redox cycling organic chemicals on the
particle surface [70]. Moreover, transition metals can
generate hydroxyl radicals through the Fenton reaction
[71]. The Fenton reaction is one of the mechanisms by
which metal impurities on or in the CNT may induce
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dence, it is plausible that ROS production could contrib-
ute to some of the infarct exacerbation that we observed
in our experiments.
Translocation and extrapulmonary toxicities of MWCNTs
were demonstrated by Reddy et al [72] while Aiso and
co-workers have shown translocation of intratracheally
instilled MWCNTs to lung associated lymph nodes [73]
such evidence may suggest a close association with the
circulatory system following exposure. Although there is
a lack of definitive studies on the translocation of
MWCNTs leading to direct particle effect on the cardiac
myocytes after oropharyngeal instillation, it could be hy-
pothesized that MWCNTs could promote infarct exacer-
bation based on the underlying translocation mechanisms
as demonstrated in the above mentioned studies.
In summary, our results show that oropharyngeal aspir-
ation of MWCNTs in mice exacerbates myocardial infarc-
tion with an increase in infarct size in a concentration-,
time- and surface modification-dependent manner. This
study was the first to assess the impact of adverse out-
comes of exposure to MWCNTs on the susceptibility of
cardiac tissue to ischemic injury. However, the mechan-
isms by which MWCNTs exposure generates cardiac tis-
sue that is susceptible to injury secondary to MWCNTs
oropharyngeal aspiration remains to be determined. The
extent of I/R injury seen at low doses, where there is a lack
of robust pulmonary response, is significant and suggests
that the cardiovascular impact should be considered
when assessing the safety of engineered nanomaterials.
Taken together, the findings are of sufficient significance
to warrant continued studies to evaluate the systemic
effects of MWCNTs associated with various exposure
conditions.
Materials and Methods
Carbon Nanotube Characterization
Three forms of chemical, vapor-deposition grown multi-
walled carbon nanotubes (MWCNTs) were generously
provided by NanoTech Labs (Yadkinville, NC). The
three forms included an unmodified commercial grade
(C-grade), acid treated carboxylated (COOH) and ni-
trogen doped (N-doped) forms. The MWCNTs were sus-
pended in a 10% Infrasurf™ surfactant/sterile normal
saline solution (a generous gift of ONY Inc. Amherst,
NY) and subjected to bath-sonication for 45 minutes
(Branson Sonicator, model 2510, Branson Ultrasonics
Corp, Danbury, CT) prior to characterization.
Electron microscopy
Detailed scanning and transmission electron microscopy
were performed using Hitachi S-4800 and 9500 micro-
scopes to define the length and diameter distribution of
the MWCNTs.Surface area measurements
The surface areas and pore volumes of the dehydrated
MWCNT suspensions were obtained using a physisorp-
tion analyzer (Micromeritics ASAP 2010) based on the
Brunauer-Emmett-Teller (BET) equation [19] and the
Barrett–Joyner–Halenda (BJH) method [20].
Thermogravimetric analysis (TGA)
Following the EDX (Energy Dispersion Xray) detection
of Fe presence, TGA analysis was performed on each of
MWCNTs to quantify the amount of residual Fe present.
The measurements were carried out using a Perkin
Elmer Thermogravimetric Analyzer (Pyris 1 TGA). Ap-
proximately 40 - 50% of the volume of the platinum pan
was filled with MWCNT (0.1 - 0.2 cm3). The sample
was heated from 30°C - 800°C at a rate of 20°C/minute
in an air atmosphere using an air flow rate of 20 ml/
minute.
Raman Spectroscopy
Raman spectra were collected using a Dilor XY triple
grating spectrometer equipped with a TE cooled CCD
at 514.5 nm Ar+ ion excitation Raman spectroscopy
has been used widely to determine the MWCNT quali-
ty using the disorder-induced (D-band) and graphitic
(G-band) bands. The ratio (R) of D-band to the G-band
integrated area (R=ID/IG) is often used to quantify the
defects in carbon nanostructures.
Dynamic Light Scattering
Hydrodynamic size distributions of the MWCNT sus-
pensions were measured using a dynamic light scattering
device (Malvern Instruments, Nanosizer S90). The sur-
face charges (and therefore suspension stability) and iso-
eletric points (IEP) of the MWCNT suspensions were
also determined using a zeta potential device (Malvern
Instruments, Zeta ZS).
Animals
6 - 8 week old male C57BL/6J mice were obtained from
Jackson Labs (Bar Harbor, Maine, USA) and were housed
and cared for by the East Carolina University Department
of Comparative Medicine Staff. All protocols conformed
to the standards in the National Institute of Health’s Guide
for the Care and Use of Laboratory Animals and were
approved by the East Carolina University Institutional
Animal Care and Use Committee. Animals were housed
on a 12/12 h light dark light cycle and provide water and
food ad libitum prior to experimental manipulation and
allowed to acclimate for 5 days prior to exposure.
MWCNT exposure
Each of the three types of MWCNTs (C-grade, COOH
and N-doped) were suspended in 10% Surfactant-Saline
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MWCNT per 100 μl suspension and orpharyngeal aspi-
ration was performed under light Isoflurane anesthesia.
Prior to oropharyngeal aspiration in mice, the MWCNTs
were bath sonicated using a cuphorn sonicator (Misonix
Model S-4000 Qsonica LLC Newton, CT) for 4 mins at
an amplitude of 65 and total of 20,807 Joules of energy.
Animals underwent I/R injury protocol at 1, 7 and 28
days following exposure for pulmonary and cardiovascu-
lar studies.
BAL collection and lung histology
Bronchoalveolar lavage was performed on the right lung
at 1 day, 7 days and 28 days post-exposure for the 1 μg
and 100 μg of the three forms of MWCNTs. The right
lung was lavaged in situ four times with ice-cold Hanks
balanced salt solution (26.25 ml/ kg body weight). The
first aliquot of bronchoalveolar lavage fluid (BALF) was
collected separately for cytokine analysis, while aliquots
2 - 4 were pooled for cell count and protein. All BALF
was centrifuged at 1000 x g for 10 minutes at 4°C. Total
cells from pooled lavage aliquots were collected and
20,000 cells were centrifuged using a Cytospin IV
(Shandon Scientific Ltd., Cheshire, UK) and stained with
a three-step hematology stain (Richard Allan Scientific,
Kalamazoo, MI, USA). Cell differential counts were deter-
mined by assessing morphology microscopically with
evaluation of 300 cells per slide [11].
Lung Histopathology
To determine histopathologic alterations, unlavaged left
lungs were collected from mice exposed to 1 μg or 100
μg each of the C-grade, COOH and N-doped MWCNTs
or from SS instilled mice. Lungs were gently inflated and
perfused with 10% neutral buffered formalin fixative and
stored for 24 - 72 hours at 4°C. Lungs were embedded
in paraffin and 8 μM cross-sections were mounted on
slides. Sections were stained with hematoxylin and eosin
(H&E) to identify tissue histological changes and MWCNT
deposition [11].
Hematology and WBC Counts
Total and differential leukocyte count, red blood cell
count and platelet count were performed on mice after
oropharyngeal aspiration of 100 μg of each of the three
forms of MWCNTs, C-grade, COOH and N-doped. The
cell counts were performed on animals not subjected to
I/R protocol. The blood counts were performed on 100
μl of whole blood using a Coulter Counter Analyzer
Model S (Coulter Corporation, Miami, Fl ) and stained
with Quick Slide Stain Pack (GG&B Co., Wichita Falls,
TX). Two slides were prepared for each animal, 100 cells
were counted per slide, counts from each animal were
averaged and the average for all animals was reported.Serum Cytokine Analysis
Serum cytokine profile analysis was performed from blood
samples collected 1 day post- oropharyngeal aspiration
of 100 μg MWCNTs (C-grade, COOH or N-doped) and
SS. The Milliplex multi-analytes kit included pro-inflam-
matory cytokines and chemotactic factors, (Lincoplex
Cytokine/Chemokine 20 plex kit Cat #: MPXMCY-
TO70KPMX220. The following analytes were detected
and measurable: Eotaxin, IL-5, IL-6, IL-10, IL-12 (p40),
IL-12(p70), IL-13, KC, MCP-1, MIP-1α and β, MIP-2 and
RANTES. A serum sample was also analyzed form a sep-
arate group of animals for cytokines IL-1β and TNF-α
using the ELISA assay (R&D systems Inc, Minneapolis,
MN). Blood samples were collected 1 day oropharyngeal
aspiration of 100 μg MWCNTs (C-grade, COOH or
N-doped) and SS. The results for IL-1β and TNF-α are
included in Table 6.
Ischemia Reperfusion (I/R) Injury Protocol
I/R injury was accomplished using an adaptation of the
protocol and as reported previously by Cozzi and Hazarika
et al [47,68]. After oropharyngeal aspiration with MWCNT
or SS, mice were anesthetized by an intraperitoneal (i.p.)
injection of Ketamine/Xylazine (18:2 mg/ml ratio with 0.05
ml/10g body weight). A midline tracheostomy was per-
formed, and the animals were intubated with #22 an-
giocath tubing and mechanically ventilated with 100%
oxygen using a Harvard Inspira ASV ventilator (Harvard
Apparatus, Holliston, MA). The initial ventilator settings
were set according to body weight tables, and adequacy of
ventilation was determined by direct visual confirmation of
satisfactory lung expansion through the subsequent open
thoracotomy. Supplemental injection of the anesthetic
mixture was provided as needed during the surgical proce-
dure to maintain anesthesia. Body temperature was main-
tained at 37°C with a TC-1000 temperature controller and
heating pad (CWE, Inc, Ardmore, PA).
A left parasternal thoracotomy was performed and the
pericardium was gently removed from the heart. The left
anterior descending coronary artery (LAD) was identi-
fied and ligated with #6-0 prolene over a #90 PE tubing
~ 4 mm distal to the origin between the conus arteriosus
and the left atrium. The location of the ligature was
chosen based on preliminary experiments indicating that
occlusion at this level placed ~ 50% of the left ventricle
at risk of ischemic injury. Effective occlusion was
confirmed visually by both the presence of pallor and
dyskinesia distal to the ligature. After 20 min of ischemia
the PE tubing was removed and reperfusion was allowed
for 2 h. The ischemic time was chosen based on prelim-
inary studies where 20 min of occlusion resulted
in a reproducible infarct size in control animals that
allowed for potential infarct expansion without increased
mortality [47].
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at the original point of occlusion and 1% Evan’s blue dye
was delivered via aortic arch cannulation to delineate
the perfused myocardium form the non-perfused myo-
cardium during ischemia [68]. After Evan’s blue staining,
the hearts were excised and 1 mm thick serial sections
were cut from the point of ligation to the apex.
Determination of Infarct size
Heart sections were incubated for a minimum of 20 min
in a 0.1% solution of 2, 3, 5-triphenyltetrazolium chloride
(TTC) to identify the infarcted from the non-infarcted
myocardium [68]. Both sides of all the sections were digi-
tally imaged and analyzed using computer planimetry soft-
ware (NIH Image J) to quantify left ventricular (LV) area,
area at risk (AAR) and infarcted area. The extent of infarct
was expressed as a percent of AAR [68].
Statistical Analysis
Data are reported as mean ± standard error of mean
(SEM). Differences in dose-response and time points bet-
ween the three groups of MWCNT were analyzed using
Microsoft Excel and Prism 5 (Graph Pad Software Inc, La
Jolla, CA). Statistical significance was determined by one-
way ANOVA with Tukey’s multiple comparison test. A
P value ≤ 0.05 was considered statistically significant.
Additional file
Additional file 1: Figure S1: Representative Raman spectra for the 3
MWCNT forms. Red traces reports raw signal and black lines fitted curve
to the signal. The Raman spectrum of MWCNT obtained using 514.5 nm
laser excitation. The presence of strong disorder band (ID/IG peak ratio)
suggests the existence of structural defects as determined by Raman
spectroscopy. Traces show the presence of the D and G band peaks
and the ratios of the strengths of these bands (R = ID/IG) are used to
quantify defects in the carbon nanostructure and reflect the defects
in the functionalized COOH and N-doped versions of the MWCNT.
Figure S2: Representative SEM image of C-grade MWCNT bundle with an
individual fiber length 38 μm. (adapted from adapted form Wang et al,
Part Fibre Toxicol. 2011:8:24). A detailed scanning electron microscopic
study reveals the lengths of indvidual C-grade MWCNTs to be in the
range of 10-100 μm. Figure S3: The diameter distribution of C-grade
MWCNTs (adapted form Wang et al, Part Fibre Toxicol. 2011:8:24 )
Fiber diameter distribution based, on TEM measurements, found a a
bi-modal distribution with peak diameters at ~12.5 nm and 27.5 nm.
Figure S4: Representative report generated for the C-grade form of the
MWCNT including SEM image, spectrum region, EDX elemental spectra
and Table with calculated percent weight and percent atoms of the
elemental components. Figure S5: A Representative SEM image of
COOH MWCNT bundle with a individual length ~78 μm. A detailed
scanning electron microscopic study reveals the lengths of indvidual
COOH MWCNTs to be in the range of 40-100 μm. Figure S6: The
diameter distribution for COOH MWCNTs. Carboxylated MWCNTs were
found have a bi-modal diameter distribution similar to C-grade MWCNTs
with peaks ~15 nm and ~30 nm. Such similar results are expected since the
carboxylation process (performed on C-grade MWCNTs) does not change
the diameter distribution significantly. Fiber diameter distribution based, on
TEM measurements. Figure S7: Representative report generated for the
COOH form of the MWCNT including SEM image, spectrum region, EDX
elemental spectra and Table with calculated percent weight and percentatoms of the elemental components. Figure S8: A representative SEM
image of N-doped MWCNTs bundle with an individual fiber length
~84 μm. A detailed scanning electron microscopic study reveals the
lengths of indvidual N-doped MWCNTs to be in the range of 50-80 μm.
Figure S9: The diameter distribution for N Doped MWCNTs Fiber diameter
distribution based, on TEM measurements. In the case of N-doped TEM
studies indicate a unimodal diameter distribution with peak at ~22.5 nm.
Figure S10: Representative report generated for the N-doped form of the
MWCNT including SEM image, spectrum region, EDX elemental spectra and
Table with calculated percent weight and percent atoms of the elemental
components. Figure S11: Histopathology of lungs 1 day post
oropharyngeal aspiration of MWCNT displays modest inflammatory
response and distributed deposition of MWCNT. Mice exposed to 10%
surfactant vehicle in saline (SS) control display normal lung morphology
while mice exposed to 1 or 100 μg MWCNTs exhibit widely dispersed
deposition of MWCNT aggregates within lung tissue. Agglomerates of
MWCNT are indicated by arrows. H&E staining demonstrates
peribronchioloar inflammatory foci in lungs of mice exposed to MWCNT
but not vehicle. Images are representative of 4 mice per group with larger
panels magnifications of 200x and insets at 400x. Figure S12:
Histopathology of lungs 7 day post oropharyngeal aspiration of MWCNT
displays modest inflammatory response and distributed deposition of
MWCNT. Mice exposed to 10% surfactant in saline (SS) control display
normal lung morphology while mice exposed to 1 or 100 μg MWCNTs
exhibit continued presence of widely dispersed deposition of MWCNT
aggregates within lung tissue. Agglomerates of MWCNT are indicated by
arrows. H&E staining demonstrates peribronchioloar and alveolar wall
inflammatory foci in lungs of mice exposed to MWCNT but not vehicle.
Images are representative of 4 mice per group with larger panels
magnifications of 200x and insets at 400x. Figure 13: Histopathology of
lungs 28 day post oropharyngeal aspiration of MWCNT displays modest
inflammatory response with granulomatous and fibrotic tissue response
and persistent distributed deposition of MWCNT. Mice exposed to 10%
surfactant in saline (SS) control display normal lung morphology while mice
exposed to 1 or 100 μg MWCNTs exhibit continued presence of widely
dispersed deposition of MWCNT aggregates within lung tissue.
Agglomerates of MWCNT are indicated by arrows. H&E staining
demonstrates peribronchioloar and alveolar wall inflammatory foci in lungs
of mice exposed to MWCNT but not vehicle. Images are representative of 4
mice per group with larger panels magnifications of 200x and insets at
400x.
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